Evidence map›Paper›PMID 7998990›Full record

ArticleThe Biochemical journal1994

Vascular smooth-muscle cells contain AT1 angiotensin receptors coupled to phospholipase D activation.

E J Freeman, E A Tallant

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Local renin-angiotensin systems in the genitourinary tract.Naunyn-Schmiedeberg's archives of pharmacology · 2012
    Review
  4. Article
  5. Article
  6. Article
  7. [The renin-angiotensin system in cardiovascular diseases].Medizinische Klinik (Munich, Germany : 1983) · 1998
    Review
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

E J FreemanCalhoun Research Laboratory, Department of Internal Medicine, Akron General Medical Center, OH 44307.
E A Tallant
Akron General Medical Center · USWake Forest University · US

Funding

CELLULAR MECHANISMS FOR ANGIOTENSIN RESPONSES IN BRAINR01NS031664 · NINDS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI TALLANT, ELISABETH ANN · 1992 to 1999
–
NINDS NIH HHS NS 31664
6 · The paper itself

Abstract

We previously showed that angiotensin II (Ang II) and angiotensin-(2-8)-peptide [Ang-(2-8)] activate a phosphoinositide-specific phospholipase C (PLC) and cause calcium mobilization in rat aortic vascular smooth-muscle cells (VSMC), while Ang II and Ang-(1-7) produce prostaglandins. To define further the signal-transduction mechanisms activated by angiotensin peptides in smooth-muscle cells, we measured diacylglycerol (DAG) accumulation in response to different angiotensin peptides and its inhibition by subtype-selective receptor antagonists. Both an initial (10 s) and secondary (10 min) phase of DAG production in response to 100 nM Ang II were inhibited by 1 microM losartan (DuP 753), an AT1 antagonist, while 1 microM PD 123177, an AT2 antagonist, was ineffective. In contrast, the heptapeptide Ang-(1-7) did not produce DAG in VSMC. Ang II also caused the hydrolysis of phosphatidylinositol and phosphatidylcholine, the formation of phosphatidic acid and the formation of phosphatidylethanol (PEt) in the presence of ethanol, through activation of a PLD and a PLD-induced transphosphatidylation reaction. A similar concentration of Ang-(2-8) also activated PLD; in contrast, Ang-(1-7) was ineffective. PEt production by 100 nM Ang II was significantly attenuated by the AT1 antagonists losartan, its metabolite EXP 3174 or L-158,809 (all at 1 microM), whereas a similar concentration of the AT2 antagonists CGP 42112A or PD 123177 was ineffective. The production of PEt by Ang II was also partially attenuated by the removal of extracellular calcium and potentiated by increasing calcium concentrations, indicating that PLD activity is partially dependent on extracellular calcium. Thus VSMC PLD is coupled to an AT1 receptor and occurs in response to Ang II or Ang-(2-8), but not Ang-(1-7). Since AT1 receptors in VSMC are also coupled to activation of PLC, both PLC and PLD may be coupled to the same or a different AT1 receptor. Alternatively, PLD may be sequentially activated in response to Ang II activation of PLC and a subsequent increase in calcium concentration.

Indexed as

Angiotensin IIAngiotensin Receptor AntagonistsAnimalsAorta, ThoracicBiphenyl CompoundsCalciumDiglyceridesEnzyme ActivationImidazolesKineticsLosartanMuscle, Smooth, VascularOligopeptidesPeptide FragmentsPhospholipase DRatsAngiotensin IIAngiotensin Receptor AntagonistsBiphenyl CompoundsCalciumCGP 42112ADiglyceridesImidazolesLosartanOligopeptidesPeptide FragmentsPhospholipase DReceptors, AngiotensinTetrazoles

Identifiers

PMID7998990
PMCPMC1137526
OpenAlexW1813918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.